{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:20:52Z","timestamp":1788366052987,"version":"build-2803163510"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Infective endocarditis (IE) carries high morbidity and mortality, largely from neurological complications. The clinical significance of chronic antithrombotic therapy remains uncertain. We assessed whether baseline antithrombotic therapy influences intracranial hemorrhage (ICH) and mortality in left-sided IE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed a prospective multicenter cohort (2008\u20132018) including all patients with definite left-sided IE. Patients were classified at diagnosis as receiving no therapy (NT), antiplatelet therapy (APT), anticoagulation (AC), or combined therapy (CAT). The primary outcome was 30-day ICH; secondary outcomes included ischemic stroke, embolic events, major bleeding, and all-cause mortality. Multivariable logistic and Cox regression models adjusted for confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 3236 patients, 182 (5.6%) developed ICH, with the highest incidence in CAT (9.5%) and AC (6.8%). Compared with NT, baseline AC was independently associated with a higher frequency of ICH (adjusted risk ratio [aRR] 1.83, 95% CI 1.16\u20132.91), with the highest risk observed in CAT (aRR 2.45, 95% CI 1.55\u20133.87). Antiplatelet therapy was not associated with ICH. Ischemic stroke rates were similar across groups. Combined anticoagulation and antiplatelet therapy independently predicted higher 1-year mortality (adjusted hazard ratio [aHR] 1.21, 95% CI 1.02\u20131.43). Independent factors associated with ICH were Staphylococcus aureus and Candida spp. IE, extracranial embolism, prior cerebrovascular disease, and septic shock.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings highlight the value of baseline antithrombotic exposure, together with microbiologic etiology and prior cerebrovascular disease, for early neurologic risk stratification at the time of IE diagnosis, informing neuroimaging decisions and multidisciplinary discussions involving infectious diseases specialists, neurologist, and cardiac surgeons among other specialists.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciag067","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T12:44:24Z","timestamp":1770209064000},"page":"203-213","source":"Crossref","is-referenced-by-count":0,"title":["Baseline Antithrombotic Therapy and Intracranial Hemorrhage Risk in Infective Endocarditis: A Multicenter Prospective Cohort Study"],"prefix":"10.1093","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6833-6625","authenticated-orcid":false,"given":"Javier T","family":"Solera","sequence":"first","affiliation":[{"name":"Unit of Infectious Diseases, Hospital Universitario 12 de Octubre, Instituto de Investigaci\u00f3n Biom\u00e9dica imas12 , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Aparicio-Minguij\u00f3n","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, Hospital Universitario 12 de Octubre, Instituto de Investigaci\u00f3n Biom\u00e9dica imas12 , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dom\u00ednguez-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitario 12 de Octubre, Instituto de Investigaci\u00f3n Biom\u00e9dica imas12 , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5706-5583","authenticated-orcid":false,"given":"Patricia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM) , Madrid ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Respiratorias-CIBERES (CB06\/06\/0058) , Madrid ,","place":["Spain"]},{"name":"Medicine Department, Universidad Complutense de Madrid , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"V\u00e1zquez-Alen","sequence":"additional","affiliation":[{"name":"Neurology Department, Hospital General Universitario Gregorio Mara\u00f1\u00f3n , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6270-7058","authenticated-orcid":false,"given":"Ana \u00c1lvarez-Ur\u00eda","family":"Miyares","sequence":"additional","affiliation":[{"name":"Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM) , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ar\u00edstides","family":"de Alarc\u00f3n","sequence":"additional","affiliation":[{"name":"Clinical Unit of Infectious Diseases, Microbiology and Parasitology (UCEIMP), Hospital Universitario Virgen del Roc\u00edo , Seville ,","place":["Spain"]},{"name":"Grupo de Resistencias bacterianas y antimicrobianos CIBERINFEC, Instituto de Biomedicina de Sevilla (IBiS) , Seville ,","place":["Spain"]},{"name":"Medicine Department, Universidad de Sevilla , Seville ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Poyato-Borrego","sequence":"additional","affiliation":[{"name":"Clinical Unit of Infectious Diseases, Microbiology and Parasitology (UCEIMP), Hospital Universitario Virgen del Roc\u00edo , Seville ,","place":["Spain"]},{"name":"Grupo de Resistencias bacterianas y antimicrobianos CIBERINFEC, Instituto de Biomedicina de Sevilla (IBiS) , Seville ,","place":["Spain"]},{"name":"Medicine Department, Universidad de Sevilla , Seville ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9259-2730","authenticated-orcid":false,"given":"M Carmen","family":"Fari\u00f1as","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Universitario Marqu\u00e9s de Valdecilla-IDIVAL , Santander ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas-CIBERINFEC, Instituto de Salud Carlos III , Madrid ,","place":["Spain"]},{"name":"University of Cantabria Medicine Department, , Santander ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8057-7755","authenticated-orcid":false,"given":"Jos\u00e9 M","family":"Mir\u00f3","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas-CIBERINFEC, Instituto de Salud Carlos III , Madrid ,","place":["Spain"]},{"name":"Infectious Diseases Department, Hospital Clinic, IDIBAPS, University of Barcelona , Barcelona ,","place":["Spain"]},{"name":"Reial Academia de Medicina de Catalunya (RAMC) , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3532-4681","authenticated-orcid":false,"given":"Miguel \u00c1ngel","family":"Goenaga-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, Hospital Universitario Donostia, IIS Biogipuzkoa , San Sebasti\u00e1n ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Ojeda-Burgos","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Preventive Medicine Unit, Hospital Universitario Virgen de la Victoria , M\u00e1laga ,","place":["Spain"]},{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga y Plataforma en Nanomedicina (IBIMA-Plataforma BIONAND) , M\u00e1laga ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Eduardo","family":"L\u00f3pez-Cort\u00e9s","sequence":"additional","affiliation":[{"name":"Medicine Department, Universidad de Sevilla , Seville ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas-CIBERINFEC, Instituto de Salud Carlos III , Madrid ,","place":["Spain"]},{"name":"Infectious Diseases and Microbiology Clinical Unit, Hospital Universitario Virgen Macarena , Seville ,","place":["Spain"]},{"name":"Instituto de Biomedicina de Sevilla (IBiS)\/CSIC , Seville ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Sousa-Regueiro","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Complejo Hospitalario A Coru\u00f1a , A Coru\u00f1a ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5333-7529","authenticated-orcid":false,"given":"Francisco","family":"L\u00f3pez-Medrano","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, Hospital Universitario 12 de Octubre, Instituto de Investigaci\u00f3n Biom\u00e9dica imas12 , Madrid ,","place":["Spain"]},{"name":"Medicine Department, Universidad Complutense de Madrid , Madrid ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas-CIBERINFEC, Instituto de Salud Carlos III , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"2026090211582358800_ciag067-B1","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jama.297.12.1354","article-title":"Contemporary clinical profile and outcome of prosthetic valve endocarditis","volume":"297","author":"Wang","year":"2007","journal-title":"JAMA"},{"key":"2026090211582358800_ciag067-B2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0140-6736(24)01098-5","article-title":"Infective endocarditis","volume":"404","author":"Li","year":"2024","journal-title":"Lancet"},{"key":"2026090211582358800_ciag067-B3","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1161\/CIRCULATIONAHA.112.000813","article-title":"Neurological complications of infective endocarditis risk factors, outcome, and impact of cardiac surgery: a multicenter observational study","volume":"127","author":"Garc\u00eda-Cabrera","year":"2013","journal-title":"Circulation"},{"key":"2026090211582358800_ciag067-B4","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/eurheartj\/ehm005","article-title":"Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study","volume":"28","author":"Thuny","year":"2007","journal-title":"Eur Heart J"},{"key":"2026090211582358800_ciag067-B5","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1097\/CCM.0b013e3182120b41","article-title":"Neurologic complications and outcomes of infective endocarditis in critically ill patients: the ENDOcardite en REAnimation prospective multicenter study","volume":"39","author":"Sonneville","year":"2011","journal-title":"Crit Care Med"},{"key":"2026090211582358800_ciag067-B6","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1001\/archinte.160.18.2781","article-title":"Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland","volume":"160","author":"Heiro","year":"2000","journal-title":"Arch Intern Med"},{"key":"2026090211582358800_ciag067-B7","doi-asserted-by":"crossref","first-page":"ofae121","DOI":"10.1093\/ofid\/ofae121","article-title":"Epidemiology and risk factors of Mycotic Aneurysm in patients with infective endocarditis and the impact of its rupture in outcomes. Analysis of a national prospective cohort","volume":"11","author":"Calder\u00f3n-Parra","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2026090211582358800_ciag067-B8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/archinte.159.5.473","article-title":"Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy","volume":"159","author":"Tornos","year":"1999","journal-title":"Arch Intern Med"},{"key":"2026090211582358800_ciag067-B9","doi-asserted-by":"crossref","first-page":"254187","DOI":"10.1155\/2014\/254187","article-title":"Usefulness of anticoagulant therapy in the prevention of embolic complications in patients with acute infective endocarditis","volume":"2014","author":"Lee","year":"2014","journal-title":"Biomed Res Int"},{"key":"2026090211582358800_ciag067-B10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10096-010-1063-3","article-title":"Warfarin therapy and incidence of cerebrovascular complications in left-sided native valve endocarditis","volume":"30","author":"Snygg-Martin","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026090211582358800_ciag067-B11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.amjmed.2019.07.059","article-title":"The effect of preexisting anticoagulation on Cerebrovascular events in left-sided infective endocarditis","volume":"133","author":"Davis","year":"2020","journal-title":"Am J Med"},{"key":"2026090211582358800_ciag067-B12","doi-asserted-by":"crossref","first-page":"100768","DOI":"10.1016\/j.jacadv.2023.100768","article-title":"Antithrombotic therapy in patients with infective endocarditis: a systematic review and meta-analysis","volume":"3","author":"Caldonazo","year":"2024","journal-title":"JACC Adv"},{"key":"2026090211582358800_ciag067-B13","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"77","author":"Otto","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026090211582358800_ciag067-B14","doi-asserted-by":"crossref","first-page":"e576S","DOI":"10.1378\/chest.11-2305","article-title":"Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Whitlock","year":"2012","journal-title":"Chest"},{"key":"2026090211582358800_ciag067-B15","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","article-title":"2023 ESC guidelines for the management of endocarditis","volume":"44","author":"Delgado","year":"2023","journal-title":"Eur Heart J"},{"key":"2026090211582358800_ciag067-B16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.thromres.2023.06.010","article-title":"Management of anticoagulation in patients with infective endocarditis","volume":"229","author":"Zhu","year":"2023","journal-title":"Thromb Res"},{"key":"2026090211582358800_ciag067-B17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2796.1992.tb00971.x","article-title":"Aspirin to prevent growth of vegetations and cerebral emboli in infective endocarditis","volume":"231","author":"Taha","year":"1992","journal-title":"J Intern Med"},{"key":"2026090211582358800_ciag067-B18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0735-1097(03)00829-5","article-title":"A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis","volume":"42","author":"Chan","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026090211582358800_ciag067-B19","doi-asserted-by":"crossref","first-page":"12933","DOI":"10.1038\/s41598-022-16681-7","article-title":"Staphylococcus aureus increases platelet reactivity in patients with infective endocarditis","volume":"12","author":"Polzin","year":"2022","journal-title":"Sci Rep"},{"key":"2026090211582358800_ciag067-B20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1159\/000538549","article-title":"Infective endocarditis and antithrombotic therapy","volume":"149","author":"Morelli","year":"2024","journal-title":"Cardiology"},{"key":"2026090211582358800_ciag067-B21","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.clinthera.2020.07.007","article-title":"Clinical outcomes associated with the use of anticoagulant and antiplatelet agents in patients undergoing treatment for infective endocarditis: a pilot study","volume":"42","author":"Pathickal","year":"2020","journal-title":"Clin Ther"},{"key":"2026090211582358800_ciag067-B22","first-page":"e1816","article-title":"Current epidemiology and outcome of infective endocarditis: a multicenter, prospective, cohort study","volume":"94","author":"Mu\u00f1oz","year":"2015","journal-title":"Medicine (United States)"},{"key":"2026090211582358800_ciag067-B23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis","volume":"30","author":"Li","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2026090211582358800_ciag067-B24","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/jamainternmed.2013.8203","article-title":"In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis","volume":"173","author":"Lalani","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2026090211582358800_ciag067-B25","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1056\/NEJMoa1112843","article-title":"Early surgery versus conventional treatment for infective endocarditis","volume":"366","author":"Kang","year":"2012","journal-title":"N Engl J Med"},{"key":"2026090211582358800_ciag067-B26","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/ejcts\/ezaa239","article-title":"Endocarditis-related stroke is not a contraindication for early cardiac surgery: an investigation among 440 patients with left-sided endocarditis","volume":"58","author":"Ruttmann","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026090211582358800_ciag067-B27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13613-023-01221-x","article-title":"Critically ill patients with infective endocarditis, neurological complications and indication for cardiac surgery: a multicenter propensity-adjusted study","volume":"14","author":"Gros","year":"2024","journal-title":"Ann Intensive Care"},{"key":"2026090211582358800_ciag067-B28","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/imj.13958","article-title":"Clinical risk factors for acute Ischaemic and Haemorrhagic stroke in patients with infective endocarditis","volume":"48","author":"Valenzuela","year":"2018","journal-title":"Intern Med J"},{"key":"2026090211582358800_ciag067-B29","doi-asserted-by":"crossref","first-page":"e0001923","DOI":"10.1128\/cmr.00019-23","article-title":"Fungal endocarditis: pathophysiology, epidemiology, clinical presentation, diagnosis, and management","volume":"36","author":"Thompson","year":"2023","journal-title":"Clin Microbiol Rev"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciag067\/66789382\/ciag067.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/83\/2\/203\/66789382\/ciag067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/83\/2\/203\/66789382\/ciag067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:58:31Z","timestamp":1788364711000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/83\/2\/203\/8465468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,6]]},"published-print":{"date-parts":[[2026,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag067","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8,15]]},"published":{"date-parts":[[2026,2,6]]}}}